Status: current, Primitive. Date: 31-Jul 2021. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 4542089017 | Relugolix (substance) | en | Fully specified name | Active | Case insensitive | SNOMED CT core |
| 4542090014 | Relugolix | en | Synonym | Active | Case insensitive | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Relugolix | Has disposition | Gonadotropin releasing hormone receptor antagonist | true | Inferred relationship | Some | ||
| Relugolix | Is a | Antineoplastic agent | true | Inferred relationship | Some | ||
| Relugolix | Is a | Gonadotropin releasing hormone receptor antagonist | true | Inferred relationship | Some | ||
| Relugolix | Is a | Substance with benzene structure | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Relugolix-containing product | Has active ingredient | True | Relugolix | Inferred relationship | Some | 1 |
| Relugolix only product | Has active ingredient | True | Relugolix | Inferred relationship | Some | 1 |
| Relugolix-containing product in oral dose form | Has active ingredient | True | Relugolix | Inferred relationship | Some | 1 |
| Relugolix only product in oral dose form | Has active ingredient | True | Relugolix | Inferred relationship | Some | 1 |
| Relugolix 120 mg oral tablet | Has BoSS | True | Relugolix | Inferred relationship | Some | 1 |
| Relugolix 120 mg oral tablet | Has precise active ingredient | True | Relugolix | Inferred relationship | Some | 1 |
Reference Sets
Substance foundation reference set
FHIR